Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Path:
Start » Living with Aspergillosis » General interest »
This page has been archived.
It is retained for reference, but it may no longer reflect current evidence, guidance, services, or practice. For up-to-date information, please use the main aspergillosis.org search or visit the relevant current information pages.
Did this page help you?
Tell us in one minute
